Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

1.

Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference.

Dür M, Coenen M, Stoffer MA, Fialka-Moser V, Kautzky-Willer A, Kjeken I, Drăgoi RG, Mattsson M, Boström C, Smolen J, Stamm TA.

Health Qual Life Outcomes. 2015 Feb 25;13(1):27. doi: 10.1186/s12955-015-0214-8.

2.

TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits.

Diogo D, Bastarache L, Liao KP, Graham RR, Fulton RS, Greenberg JD, Eyre S, Bowes J, Cui J, Lee A, Pappas DA, Kremer JM, Barton A, Coenen MJ, Franke B, Kiemeney LA, Mariette X, Richard-Miceli C, Canhão H, Fonseca JE, de Vries N, Tak PP, Crusius JB, Nurmohamed MT, Kurreeman F, Mikuls TR, Okada Y, Stahl EA, Larson DE, Deluca TL, O'Laughlin M, Fronick CC, Fulton LL, Kosoy R, Ransom M, Bhangale TR, Ortmann W, Cagan A, Gainer V, Karlson EW, Kohane I, Murphy SN, Martin J, Zhernakova A, Klareskog L, Padyukov L, Worthington J, Mardis ER, Seldin MF, Gregersen PK, Behrens T, Raychaudhuri S, Denny JC, Plenge RM.

PLoS One. 2015 Apr 7;10(4):e0122271. doi: 10.1371/journal.pone.0122271. eCollection 2015.

3.

A first step towards personalized medicine in osteosarcoma: Pharmacogenetics as predictive marker of outcome after chemotherapy based treatment.

Hagleitner MM, Coenen MJ, Gelderblom H, Makkinje RR, Vos HI, de Bont ES, van der Graaf WT, Schreuder HB, Flucke UE, van Leeuwen FN, Hoogerbrugge PM, Guchelaar HJ, Te Loo DM.

Clin Cancer Res. 2015 Mar 31. pii: clincanres.2638.2014. [Epub ahead of print]

PMID:
25829401
4.

Effect of Dipyridamole on Myocardial Reperfusion Injury. A Double-Blind Randomized Controlled Trial in Patients Undergoing Elective Coronary Artery Bypass Surgery.

El Messaoudi S, Wouters CW, van Swieten HA, Pickkers P, Noyez L, Kievit PC, Abbink EJ, Rasing-Hoogveld A, Bouw TP, Peters JG, Coenen MJ, Rogier A, Donders T, Riksen NP, Rongen GA.

Clin Pharmacol Ther. 2015 Mar 13. doi: 10.1002/cpt.106. [Epub ahead of print]

PMID:
25773594
5.

Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.

Hagleitner MM, Coenen MJ, Patino-Garcia A, de Bont ES, Gonzalez-Neira A, Vos HI, van Leeuwen FN, Gelderblom H, Hoogerbrugge PM, Guchelaar HJ, Te Loo MW.

PLoS One. 2014 Dec 31;9(12):e115869. doi: 10.1371/journal.pone.0115869. eCollection 2014.

6.

High-quality genotyping data from formalin-fixed, paraffin-embedded tissue on the drug metabolizing enzymes and transporters plus array.

Vos HI, van der Straaten T, Coenen MJ, Flucke U, te Loo DM, Guchelaar HJ.

J Mol Diagn. 2015 Jan;17(1):4-9. doi: 10.1016/j.jmoldx.2014.08.003.

PMID:
25528187
7.

Effects of selenium supplementation on selenium status of farmed fallow deer in outdoor pens.

Stoebe S, Müller AS, Most E, Coenen M, Vervuert I.

J Trace Elem Med Biol. 2015 Jan;29:216-21.

PMID:
25468192
8.

The influence of glyphosate on the microbiota and production of botulinum neurotoxin during ruminal fermentation.

Ackermann W, Coenen M, Schrödl W, Shehata AA, Krüger M.

Curr Microbiol. 2015 Mar;70(3):374-82. doi: 10.1007/s00284-014-0732-3. Epub 2014 Nov 19.

PMID:
25407376
9.

Is there a role for the MTHFR 677C>T and 1298A>C polymorphisms in methotrexate-induced liver toxicity?

te Loo DM, Hagleitner MM, Coenen MJ.

Pharmacogenomics. 2014 Aug;15(11):1401-3. doi: 10.2217/pgs.14.82. No abstract available.

10.

What explains functioning from the perspective of people with multiple sclerosis?

Conrad A, Coenen M, Kesselring J, Cieza A.

J Neurol. 2014 Dec;261(12):2283-95. doi: 10.1007/s00415-014-7467-8. Epub 2014 Sep 11.

PMID:
25209852
11.

Nanostructuring of self-assembled porphyrin networks at a solid/liquid interface: local manipulation under global control.

Coenen MJ, Khoury T, Crossley MJ, Hendriksen BL, Elemans JA, Speller S.

Chemphyschem. 2014 Nov 10;15(16):3484-8. doi: 10.1002/cphc.201402449. Epub 2014 Aug 21.

PMID:
25146424
12.

Content validity of the Comprehensive ICF Core Set for multiple sclerosis from the perspective of speech and language therapists.

Renom M, Conrad A, Bascuñana H, Cieza A, Galán I, Kesselring J, Coenen M.

Int J Lang Commun Disord. 2014 Nov;49(6):672-86. doi: 10.1111/1460-6984.12086. Epub 2014 Aug 18.

PMID:
25134658
13.

Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis.

Umićević Mirkov M, Janss L, Vermeulen SH, van de Laar MA, van Riel PL, Guchelaar HJ, Brunner HG, Albers CA, Coenen MJ.

Ann Rheum Dis. 2014 Aug 11. pii: annrheumdis-2014-205541. doi: 10.1136/annrheumdis-2014-205541. [Epub ahead of print]

PMID:
25114059
14.

TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathy.

Hofstra JM, Coenen MJ, Schijvenaars MM, Berden JH, van der Vlag J, Hoefsloot LH, Knoers NV, Wetzels JF, Nijenhuis T.

PLoS One. 2014 Jul 14;9(7):e102065. doi: 10.1371/journal.pone.0102065. eCollection 2014.

15.

What explains health in persons with visual impairment?

Leissner J, Coenen M, Froehlich S, Loyola D, Cieza A.

Health Qual Life Outcomes. 2014 May 3;12:65. doi: 10.1186/1477-7525-12-65.

16.

X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.

Donker AE, Raymakers RA, Nieuwenhuis HK, Coenen MJ, Janssen MC, MacKenzie MA, Brons PP, Swinkels DW.

Neth J Med. 2014 May;72(4):210-7.

17.

Narratives reflecting the lived experiences of people with brain disorders: common psychosocial difficulties and determinants.

Hartley S, McArthur M, Coenen M, Cabello M, Covelli V, Roszczynska-Michta J, Pitkänen T, Bickenbach J, Cieza A.

PLoS One. 2014 May 7;9(5):e96890. doi: 10.1371/journal.pone.0096890. eCollection 2014.

18.

Full-gene sequencing analysis of NAT2 and its relationship with isoniazid pharmacokinetics in Venezuelan children with tuberculosis.

Verhagen LM, Coenen MJ, López D, García JF, de Waard JH, Schijvenaars MM, Hermans PW, Aarnoutse RE.

Pharmacogenomics. 2014 Feb;15(3):285-96. doi: 10.2217/pgs.13.230.

PMID:
24533708
19.

A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides.

Bossini-Castillo L, de Kovel C, Kallberg H, van 't Slot R, Italiaander A, Coenen M, Tak PP, Posthumus MD, Wijmenga C, Huizinga T, van der Helm-van Mil AH, Stoeken-Rijsbergen G, Rodriguez-Rodriguez L, Balsa A, González-Álvaro I, González-Gay MÁ, Gómez-Vaquero C, Franke B; LifeLines Cohort Study, Vermeulen S, van der Horst-Bruinsma Ie, Dijkmans BA, Wolbink GJ, Ophoff RA, Maehlen MT, van Riel P, Merriman M, Klareskog L, Lie BA, Merriman T, Crusius JB, Brouwer E, Martin J, de Vries N, Toes R, Padyukov L, Koeleman BP.

Ann Rheum Dis. 2015 Mar;74(3):e15. doi: 10.1136/annrheumdis-2013-204591. Epub 2014 Feb 14.

PMID:
24532677
20.

Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene.

Okada Y, Diogo D, Greenberg JD, Mouassess F, Achkar WA, Fulton RS, Denny JC, Gupta N, Mirel D, Gabriel S, Li G, Kremer JM, Pappas DA, Carroll RJ, Eyler AE, Trynka G, Stahl EA, Cui J, Saxena R, Coenen MJ, Guchelaar HJ, Huizinga TW, Dieudé P, Mariette X, Barton A, Canhão H, Fonseca JE, de Vries N, Tak PP, Moreland LW, Bridges SL Jr, Miceli-Richard C, Choi HK, Kamatani Y, Galan P, Lathrop M, Raj T, De Jager PL, Raychaudhuri S, Worthington J, Padyukov L, Klareskog L, Siminovitch KA, Gregersen PK, Mardis ER, Arayssi T, Kazkaz LA, Plenge RM.

PLoS One. 2014 Feb 10;9(2):e87645. doi: 10.1371/journal.pone.0087645. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk